The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma-Reference-Cited by-同舟云学术

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Published:2020-06 Issue:6 Volume:26 Page:832-844.e6
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Vora Parvez,Venugopal Chitra,Salim Sabra Khalid,Tatari Nazanin,Bakhshinyan David,Singh Mohini,Seyfrid Mathieu,Upreti Deepak,Rentas Stefan,Wong Nicholas,Williams Rashida,Qazi Maleeha Ahmad,Chokshi Chirayu,Ding Avrilynn,Subapanditha Minomi,Savage Neil,Mahendram Sujeivan,Ford Emily,Adile Ashley Ann,McKenna Dillon,McFarlane Nicole,Huynh Vince,Wylie Ryan Gavin,Pan James,Bramson Jonathan,Hope Kristin,Moffat Jason,Singh Sheila

Funder

Terry Fox Research Institute

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference80 articles.

1. TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma;Anido;Cancer Cell,2010

2. CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells;Arndt;Proc. Natl. Acad. Sci. USA,2013

3. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006

4. Targeting cancer stem cells through L1CAM suppresses glioma growth;Bao;Cancer Res.,2008

5. Convection-enhanced delivery of macromolecules in the brain;Bobo;Proc. Natl. Acad. Sci. USA,1994

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion;Life Sciences;2024-10

2. Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer;Science Advances;2024-08-30

3. CAR-based therapeutic targets in pediatric high-grade glioma;2024-08-28

4. Engineering Cells for Cancer Therapy;Accounts of Chemical Research;2024-08-02

5. Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells;Nature Medicine;2024-08-02